Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BELANTAMAB MAFODOTIN Cause Pleural effusion? 9 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Pleural effusion have been filed in association with BELANTAMAB MAFODOTIN (Blenrep). This represents 0.4% of all adverse event reports for BELANTAMAB MAFODOTIN.

9
Reports of Pleural effusion with BELANTAMAB MAFODOTIN
0.4%
of all BELANTAMAB MAFODOTIN reports
7
Deaths
4
Hospitalizations

How Dangerous Is Pleural effusion From BELANTAMAB MAFODOTIN?

Of the 9 reports, 7 (77.8%) resulted in death, 4 (44.4%) required hospitalization, and 1 (11.1%) were considered life-threatening.

Is Pleural effusion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BELANTAMAB MAFODOTIN. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does BELANTAMAB MAFODOTIN Cause?

Keratopathy (788) Visual acuity reduced (708) Death (499) Plasma cell myeloma (380) Dry eye (359) Night blindness (317) Photophobia (183) Foreign body sensation in eyes (151) Vision blurred (134) Ocular toxicity (94)

What Other Drugs Cause Pleural effusion?

DASATINIB (2,424) METHOTREXATE (1,310) CYCLOPHOSPHAMIDE (1,239) IBRUTINIB (1,205) RITUXIMAB (1,168) PREDNISONE (1,144) NIVOLUMAB (1,061) ADALIMUMAB (1,036) DEXAMETHASONE (879) PACLITAXEL (862)

Which BELANTAMAB MAFODOTIN Alternatives Have Lower Pleural effusion Risk?

BELANTAMAB MAFODOTIN vs BELANTAMAB MAFODOTIN-BLMF BELANTAMAB MAFODOTIN vs BELATACEPT BELANTAMAB MAFODOTIN vs BELIMUMAB BELANTAMAB MAFODOTIN vs BELINOSTAT BELANTAMAB MAFODOTIN vs BELUMOSUDIL

Related Pages

BELANTAMAB MAFODOTIN Full Profile All Pleural effusion Reports All Drugs Causing Pleural effusion BELANTAMAB MAFODOTIN Demographics